David Tapolczay

David Tapolczay

Chief Executive Officer at CONDUIT PHARMACEUTICALS INC.

Net worth: 6 M $ as of 31/05/2024

64 year
Commercial Services
Health Technology
Consumer Services

David Tapolczay active positions

CompaniesPositionStartEnd
CONDUIT PHARMACEUTICALS INC. Director/Board Member 22/09/2023 -
Chief Executive Officer 22/09/2023 -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Career history of David Tapolczay

Former positions of David Tapolczay

CompaniesPositionStartEnd
NUFORMIX PLC Chairman 01/01/2008 05/02/2020
Founder 01/01/2008 05/02/2020
Chairman 23/10/2007 05/02/2020
Founder 23/10/2007 05/02/2020
Chief Executive Officer 18/01/2011 01/12/2018
Chief Tech/Sci/R&D Officer 01/12/2005 01/04/2007
Nanoform Cardiovascular Therapeutics Ltd. Director/Board Member - -
░░░░░░░░░░░░░ ░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ - -
░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ - -
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ - -
░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░ -
░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░ - -
░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ - -
░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -

Training of David Tapolczay

Southampton Business School Doctorate Degree

Statistics

International

United Kingdom 18
United States 3
Romania 2

Operational

Director/Board Member 6
Chief Executive Officer 5
Chairman 4

Sectoral

Commercial Services 10
Health Technology 7
Consumer Services 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies2
BICYCLE THERAPEUTICS PLC

Health Technology

NUFORMIX PLC

Health Technology

Private companies18

Commercial Services

Zeneca Agrochemicals

Commercial Services

Glaxo Smithkline Plc /Clinical Pharmacology Unit/

Commercial Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

GSK Group Ltd.

Health Technology

Health Technology

Stylacats Ltd.

Commercial Services

Commercial Services

Nanoform Cardiovascular Therapeutics Ltd.

Conduit Pharmaceuticals, Inc.

Health Technology

See company connections